Showing results 1 to 3 of 3
Issue Date | Title | Author(s) | Type |
---|---|---|---|
2014 | A Comparison of the Efficacy and Safety of Entecavir Versus Lamivudine Through 240 Weeks of Treatment in Korean Patients with HBeAg-negative Chronic Hepatitis B | 김태헌 | Meeting Abstract |
2007 | Hepatitis B surface antigen titer was decreased during clevudine therapy | 유권 | Meeting Abstract |
2006 | Six month maintenance therapy with 10 mg clevudine maintains the viral suppression and biochemical improvement achieved with six months therapy with 30 mg | 유권 | Meeting Abstract |